In particular, among the 32 types of cancer species from 50 studies involving 13679 people (http://cbioportal.org), we found that the amplification mutations of CAV1, CAV2, and FLOT1 were primarily singled out in cutaneous melanoma (Fig. 1A–C). This evidence concerns the gene FLOT1 and cutaneous melanoma.